According to a recent study being presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, Baked Milk Oral Immunotherapy (BMOIT) is well-tolerated a… Read More
WASHINGTON — Treatment with benralizumab (Fasenra) was noninferior to mepolizumab (Nucala) for relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA), the ran… Read More
Majority of patients were attack free during the entire six-month treatment period (61.5%)
Study results presented for first time at 2023 AAAAI Annual Meeting; global regulatory submissio… Read More
SAN DIEGO, March 04, 2017 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unm… Read More